World Anti-Doping Agency and Partnership for Clean Competition funded anabolic steroids

1-Androstendione (5α-Androst-1-en-3,17-dione) *

2α-Hydroxymethylethisterone*

19-Noretiocholanolone sulfate (Na salt)*

7a-methylnandrolone

Carboxy finasteride^† 

4-Hydroxy-estr-4-en-3,17-dione   

1,6,7-d3-4-Hydroxyandrostendione

17α-Methyl-4-chloroandrost-4-ene-3α,17β-diol

Methyldienolone^†

Norbolethone

13β,17α-Diethyl-5β-gonane-3α, 17β-diol (major metabolite)*

13β,17α-Diethyl-5α-gonane-3α, 17β-diol (minor metabolite)*

6β-Hydroxy-oral turinabol^†

d₄-5α-Androstan-3α, 17β-diol-17-O- β-glucuronic acid

D₄-5α-Androstan-3α,17β-diol-3-O-β-glucuronic acid*

D₃-5β-Androstan-3α,17β-diol-17-O-β-glucuronic acid*

D₅-5β-Androstan-3α,17β-diol-3-O-β-glucuronic acid*

d₄-Epitestsosterone-17-O-β-glucuronic acid

D₅-Etiocholanolone-3-O-β-glucuronide sodium salt*

5α-Androst-1-ene-3α-ol-17-one*

3α-5-Cyclo-5α-androstane-6β-ol-17-one

16α-Hydroxyandrosterone

6β-Hydroxyetiocholanolone

4β-Hydroxy DHEA*

7-Keto DHEA*

7α-HydroxyDHEA

16β-Hydroxy DHEA*

3α-Hydroxyestrenone

3β-Hydroxy-4-estren-17-one*

7β-Hydroxy DHEA

N-[(4-Chlorophenyl)methyl]-5-nitro-2-thiophenemethanamine hydrochloride^† 

Ethyl N-(5-nitro-2-methylthiophene)-3-aminomethylpyrrolidine-1-carboxylate^† 

Formoterol fumarate^†

Higenamine hydrochloride^† 

Carbon isotope delta value reported for 5α-androstan-3β-ol acetate (d¹³C_VPDB / ‰ -32.00 ± 0.09), 5α-androstan-3α-ol-17-one acetate (d¹³C_VPDB / ‰ -32.58 ± 0.03), 5β-androstan-3α-ol-11,17-dione acetate (d¹³C_VPDB / ‰ -16.50 ± 0.03), and 5α-cholestane (d¹³C_VPDB / ‰ -24.90 ± 0.05) ^†

Carbon isotope delta value reported for 5β-androstan-3α-ol-17-one (d¹³C_VPDB / ‰ -28.75 ± 0.01), 5α-androstan-3α-ol-17-one (d¹³C_VPDB / ‰ -26.74 ± 0.03), 5β-pregnan-3α, 20a-diol (d¹³C_VPDB / ‰ -18.65 ± 0.03) ^†

Carbon isotope delta value reported for 5α-androstan-3α-ol-17-one (d¹³C_VPDB / ‰ -27.09 ± 0.07) ^†

Carbon isotope delta value reported for 5α-androstan-3α-ol-17-one acetate (d¹³C_VPDB / ‰ -32.82 ± 0.02)^†

Carbon isotope delta value reported for 5α-cholestane (d¹³C_VPDB / ‰ -25.03 ± 0.01) ^†

Carbon isotope delta value reported for 5α-androstan-3α-ol-17-one acetate (d¹³C_VPDB / ‰ -32.73 ± 0.06), 5β-androstan-3α, 17β-diacetate (d¹³C_VPDB / ‰ -30.19 ± 0.07), 5α-cholestane (d¹³C_VPDB / ‰ -24.83 ± 0.13), and 5β- pregnan-3α, 20a-diacetate (d¹³C_VPDB / ‰ -21.16 ± 0.08) ^†

Carbon Isotope Delta Value of Boldenone* (d13CVPDB / ‰ –30.38 ± 0.29)
Boldenone* Metabolite 1 (d13CVPDB / ‰  –30.38 ± 0.29)

Carbon Isotope Delta Value of Formestane* (d13CVPDB / ‰ –30.71 ± 0.48)

19-Noretiocholanolone sulfate (Na salt)*

Methyldienolone^†

Norbolethone

6β-Hydroxy-oral turinabol^†

d₄-5α-Androstan-3α, 17β-diol-17-O- β-glucuronic acid

D₄-5α-Androstan-3α,17β-diol-3-O-β-glucuronic acid*

D₃-5β-Androstan-3α,17β-diol-17-O-β-glucuronic acid*

D₅-5β-Androstan-3α,17β-diol-3-O-β-glucuronic acid*

d₄-Epitestsosterone-17-O-β-glucuronic acid

D₅-Etiocholanolone-3-O-β-glucuronide sodium salt*

5α-Androst-1-ene-3α-ol-17-one*

3α-5-Cyclo-5α-androstane-6β-ol-17-one

16α-Hydroxyandrosterone

6β-Hydroxyetiocholanolone

4β-Hydroxy DHEA*

7-Keto DHEA*

7α-HydroxyDHEA

16β-Hydroxy DHEA*

3α-Hydroxyestrenone

3β-Hydroxy-4-estren-17-one*

α-Hydroxycarprofen^† 

N-[(4-Chlorophenyl)methyl]-5-nitro-2-thiophenemethanamine hydrochloride^† 

Ethyl N-(5-nitro-2-methylthiophene)-3-aminomethylpyrrolidine-1-carboxylate^† 

Formoterol fumarate^†

Higenamine hydrochloride^† 

19-Norandrosterone* (221.4 ng/g) in

1,2-dimethoxyethane (1 mL)

Carbon Isotope Delta Value of 19-norandrosterone

in Water containing 20% Methanol 1 (mL) *

d¹³C_VPDB / ‰ –29.7 ± 0.8

Mass fraction of testosterone metabolites in freeze dried human urine*: 5α-androstane-3α-17β-diol (41.2 ± 1.8 ng/g), 5β‑androstane-3α-17β-diol (66.0 ± 2.9 ng/g), androsterone 1652 ± 29 ng/g), etiocholanolone (1359 ± 34 ng/g), testosterone (88.1 ± 4.2 ng/g), epitestosterone (21.9 ± 1.0 ng/g), T/E mass ratio (4.03 ± 0.26)

Carbon Isotope Delta Values:
MX018-1: Etiocholanolone † (d13CVPDB / ‰    –27.94 ± 0.24), Androsterone † (d13CVPDB / ‰   –27.79 ± 0.21), 11-oxoetiocholanolone † (d13CVPDB / ‰   –13.58 ± 0.23),
Testosterone † (d13CVPDB / ‰  –27.87 ± 0.24), 11β-hydroxyetiocholanolone † (d13CVPDB / ‰     –29.51 ± 0.36),
MX018-2: 5β-androstane-3α,17β-diol † (d13CVPDB / ‰     –29.86 ± 0.16), 5α-androstane-3α,17β-diol † (d13CVPDB / ‰   –31.14 ± 0.24), Pregnanediol † (d13CVPDB / ‰  –16.79 ± 0.42), Epitestosterone † (d13CVPDB / ‰   –30.17 ± 0.36), 11β-hydroxyandrosterone † (d13CVPDB / ‰  –28.59 ± 0.22),
MX018-3: 16-androstenol † (d13CVPDB / ‰  –30.96 ± 0.37), Dehydroepiandrosterone † (d13CVPDB / ‰  –31.63 ± 0.54), Testosterone † (d13CVPDB / ‰    –22.52 ± 0.33)

Epinandrolone sulfate TEA salt

13β,17α-Diethyl-5β-gonane-3α, 17β-diol (major metabolite)*

13β,17α-Diethyl-5α-gonane-3α, 17β-diol (minor metabolite)*

7β-Hydroxy DHEA

5β-Androstane-3α, 17β-diol-3-O-β-glucuronic acid

7a-methyl-5b-estran-3a-ol-17-one

7a-methylnandrolone

Carbon Isotope Delta Value of 19-norandrosterone in freeze dried human urine * (d13CVPDB / ‰   –29.82 ± 0.41), Etiocholanolone  (d13CVPDB / ‰   -23.60 ± 0.51), Androsterone (d13CVPDB / ‰   -22.27 ± 0.57), Testosterone (d13CVPDB / ‰   -27.48 ± 0.73), Epitestosterone (d13CVPDB / ‰   -23.74 ± 0.80), 5a-androstane-3a,17b-diol (d13CVPDB / ‰   -23.83 ± 0.90), 5b-androstane-3a,17b-diol (d13CVPDB / ‰   -23.76 ± 0.61), 11-oxoetiocholanolone (d13CVPDB / ‰   -22.23 ± 0.48), 11b-hydroxyandrosterone (d13CVPDB / ‰   -22.38 ± 0.64), Pregnanediol (d13CVPDB / ‰   -22.79 ± 0.77), 16-androstenol (d13CVPDB / ‰   -22.51 ± 0.60)

Carbon Isotope Delta Value of Boldenone* (d13CVPDB / ‰ –30.38 ± 0.29)
Boldenone* Metabolite 1 (d13CVPDB / ‰  –30.38 ± 0.29)

Carbon Isotope Delta Value of Formestane* (d13CVPDB / ‰ –30.71 ± 0.48)

7a-Methyl-estr-4-ene-3a-ol-17-one (WADA material)

1,6,7-d3-4-Hydroxyandrostendione

19-Norandrosterone* (221.4 ng/g) in

1,2-dimethoxyethane (1 mL)

Carbon Isotope Delta Value of 19-norandrosterone

in Water containing 20% Methanol 1 (mL) *

d¹³C_VPDB / ‰ –29.7 ± 0.8

Mass fraction of testosterone metabolites in freeze dried human urine*: 5α-androstane-3α-17β-diol (41.2 ± 1.8 ng/g), 5β‑androstane-3α-17β-diol (66.0 ± 2.9 ng/g), androsterone 1652 ± 29 ng/g), etiocholanolone (1359 ± 34 ng/g), testosterone (88.1 ± 4.2 ng/g), epitestosterone (21.9 ± 1.0 ng/g), T/E mass ratio (4.03 ± 0.26)

Carbon Isotope Delta Values:
MX018-1: Etiocholanolone † (d13CVPDB / ‰    –27.94 ± 0.24), Androsterone † (d13CVPDB / ‰   –27.79 ± 0.21), 11-oxoetiocholanolone † (d13CVPDB / ‰   –13.58 ± 0.23),
Testosterone † (d13CVPDB / ‰  –27.87 ± 0.24), 11β-hydroxyetiocholanolone † (d13CVPDB / ‰     –29.51 ± 0.36),
MX018-2: 5β-androstane-3α,17β-diol † (d13CVPDB / ‰     –29.86 ± 0.16), 5α-androstane-3α,17β-diol † (d13CVPDB / ‰   –31.14 ± 0.24), Pregnanediol † (d13CVPDB / ‰  –16.79 ± 0.42), Epitestosterone † (d13CVPDB / ‰   –30.17 ± 0.36), 11β-hydroxyandrosterone † (d13CVPDB / ‰  –28.59 ± 0.22),
MX018-3: 16-androstenol † (d13CVPDB / ‰  –30.96 ± 0.37), Dehydroepiandrosterone † (d13CVPDB / ‰  –31.63 ± 0.54), Testosterone † (d13CVPDB / ‰    –22.52 ± 0.33)

Carbon Isotope Delta Value of 19-norandrosterone in freeze dried human urine * (d13CVPDB / ‰   –29.82 ± 0.41), Etiocholanolone  (d13CVPDB / ‰   -23.60 ± 0.51), Androsterone (d13CVPDB / ‰   -22.27 ± 0.57), Testosterone (d13CVPDB / ‰   -27.48 ± 0.73), Epitestosterone (d13CVPDB / ‰   -23.74 ± 0.80), 5a-androstane-3a,17b-diol (d13CVPDB / ‰   -23.83 ± 0.90), 5b-androstane-3a,17b-diol (d13CVPDB / ‰   -23.76 ± 0.61), 11-oxoetiocholanolone (d13CVPDB / ‰   -22.23 ± 0.48), 11b-hydroxyandrosterone (d13CVPDB / ‰   -22.38 ± 0.64), Pregnanediol (d13CVPDB / ‰   -22.79 ± 0.77), 16-androstenol (d13CVPDB / ‰   -22.51 ± 0.60)

α-Hydroxycarprofen^† 

Epinandrolone sulfate TEA salt